优化介酶干细胞外细胞囊泡用于慢性伤口愈合:生物工程,标准化和安全性
Yusuke Shimizu1, Edward Hosea Ntege1, Yoshikazu Inoue2
1Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Nakagami, Okinawa, 903-0215, Japan.
Regenerative therapy
|July 9, 2024
概括
工程化介质干细胞 (MSC) 衍生的细胞外囊泡 (EVs) 显示为慢性伤口的纳米疗法具有前景. 生物工程策略旨在改善它们的输送和治疗载荷,克服临床使用的挑战.
科学领域:
- 再生医学是一种再生医学.
- 纳米技术 纳米技术
- 生物材料是一种生物材料.
背景情况:
- 慢性伤害全球数百万人,标准治疗通常由于炎症和组织再生不良而失败.
- 介质干细胞 (MSC) 衍生的细胞外囊泡 (EVs) 正成为一个有前途的无细胞治疗替代品.
- 电动汽车作为天然的纳米级输送系统,携带来自干细胞的治疗生物分子.
研究的目的:
- 审查生物工程策略,以开发MSC-EV成为用于慢性伤口愈合的精密纳米疗法.
- 突出新兴技术,以提高MSC-EV的功能和生产.
- 确定挑战,并为临床翻译提出解决方案.
主要方法:
- 对MSC-EVs应用的生物工程技术的当前文献的审查.
- 检查包括CRISPR基因编辑,微流体制造和仿生系统在内的先进技术.
- 分析改善电动汽车定位,货物优化和可扩展生产的策略.
主要成果:
- 生物工程方法可以提高MSC-EV准,治疗性货物装载和制造一致性.
- 像CRISPR,微流体学和仿生系统这样的技术为先进的MSC-EV疗法提供了潜力.
- 关键的挑战包括批量变异性,安全性评估 (瘤起源性,免疫性) 和生物分布.
结论:
- 设计的MSC-EV代表了慢性伤口再生纳米医学的重大进步.
- 克服制造,安全和监管障碍对于临床翻译至关重要.
- 合作努力对于实现现成的MSC-EV疗法的潜力至关重要.
更多相关视频
07:03Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
Published on: September 23, 2022
2.0K
09:48Large-Scale Preparation of Synovial Fluid Mesenchymal Stem Cell-Derived Exosomes by 3D Bioreactor Culture
Published on: July 26, 2022
4.3K
相关概念视频
01:19Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
01:19Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K